Form 4 for ACET Adicet Bio, Inc.
Accepted 2025-06-13 00:00:00 ET · period of report 2025-06-11 · accession 0000950170-25-086135 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-13 | 2025-06-11 | ACET | Sinclair Andrew | Dir | A - Grant | $0.00 | +5,900 | 17.7K | +50% | $0 |
| D | 2025-06-13 | 2025-06-11 | ACET | Sinclair Andrew | Dir | A - Grant | $0.00 | +26.4K | 26.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-11 | A | A | 5,900 | $0.00 | 17,700 | D | — | — | (F1) The Reporting Person was issued Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors. The RSUs may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-06-11 | A | A | 26,400 | $0.00 | 26,400 | D | $0.78 · — to 2035-06-10 | 26,400 Common Stock | (F2) These shares shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors. |